The Origin of JY BioMed: From a Pharmacy in Wanhua to Cell Therapy and Biotech Innovation

A story of biotech innovation began in a small pharmacy in Wanhua, Taipei.

In one of the city’s most grounded neighborhoods, our founder, Dr. Ethan Shen, spent years working closely with patients and their families. These everyday interactions did not come with complex data—but they revealed something real and consistent:

While medicine can relieve symptoms, many lives remain unchanged.

This realization did not happen overnight. It emerged gradually, through repeated encounters and familiar situations. As the same patterns continued to appear, a deeper question began to take shape: if healthcare can only go this far, is there a way to go further?

That question became the starting point of JY BioMed.

From the founding of YD Bio to the establishment of JY BioMed, we chose to focus on cell therapy, regenerative medicine, and cancer-related technologies. This was not simply a shift in business direction—it was a rethinking of what healthcare could become: moving from symptom management toward changing the course of disease.

The path is not easy, but it is grounded in a simple intention—to go beyond temporary relief and work toward meaningful change.

What began in Wanhua has since expanded into laboratories, clinical research, and global collaborations, as we continue to explore new possibilities in advanced therapeutics.

As seen in later stages of this journey, these beginnings have also contributed to bringing Taiwan’s biotech innovation onto the global stage .

Yet for JY BioMed, how far we go matters less than where we began.

Because the moments we have seen—and cannot forget—are what continue to move us forward.